Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
- Conditions
- Menopause
- Registration Number
- NCT00141570
- Lead Sponsor
- Solvay Pharmaceuticals
- Brief Summary
To determine whether treatment with ESTRATEST® H.S. Tablets is superior to treatment with esterified estrogens tablets
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 350
Menopausal women between the ages of 30 and 65 years (inclusive) with symptoms of estrogen and/or androgen deficiency not currently controlled by estrogen therapy as determined by patient report and the Investigator's clinical judgement
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change from baseline in the total score of the Menopause Rating Scale (MRS) at Week 12
- Secondary Outcome Measures
Name Time Method Change from baseline in the MRS at Week 12 & monthly change from baseline to Week 12 in the MENQOL; Comparison of changes in SHBG & testosterone & how these changes correlate with the MRS
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (77)
Site 66
🇺🇸Huntsville, Alabama, United States
Site 57
🇺🇸Mobile, Alabama, United States
Site 46
🇺🇸Montgomery, Alabama, United States
Site 29
🇺🇸Phoenix, Arizona, United States
Site 15
🇺🇸Tucson, Arizona, United States
Site 3
🇺🇸Jonesboro, Arkansas, United States
Site 22
🇺🇸Little Rock, Arkansas, United States
Site 68
🇺🇸Carmichael, California, United States
Site 55
🇺🇸Encinitas, California, United States
Site 6
🇺🇸San Diego, California, United States
Scroll for more (67 remaining)Site 66🇺🇸Huntsville, Alabama, United States